powered by centersite dot net
Medications
Resources
Basic InformationLatest News
3MR Intervention Effective for Discontinuing Inappropriate MedsDoes a Drug's High Price Tag Cause Its Own Side Effects?Commercialization of Generics Impacts Adverse Event RatesProcess Promising for On-Site Printing of Custom-Dosed MedsHealth Tip: Medication Use After a Natural DisasterFew Older Patients Aware of DeprescribingHealth Tip: Medication Suggestions for Older AdultsPhysicians Tweeting About Drugs May Have Conflict of InterestWhite Kids More Likely to Get Unneeded AntibioticsNew Cholesterol Drugs Vastly Overpriced, Study ContendsFDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsHealth Tip: Throwing Out Leftover MedicineFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?U.S. Antidepressant Use Jumps 65 Percent in 15 YearsThe Fine Print on Medication Expiration DatesAmericans Taking More Prescription Drugs Than Ever: SurveyInappropriate Med Use High in Cognitively Impaired SeniorsA Reminder That Meds and Grapefruit Don't Always MixAspirin Responsiveness Can Change After Bariatric SurgerySome Medicines Boost Sensitivity to SunPainkiller Prescriptions More Prone to Errors If HandwrittenMedication Mistakes Have Doubled in U.S. Since 2000: StudyMarket Competition Linked to Change in Generic Drug PricesIs Your Child's 'Penicillin Allergy' Real?FDA Seeks to Increase Number of Generic Drugs on MarketWhen Is an Opioid Safe to Take?Lifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyBirth Control Pills Recalled Due to Danger of Unintended PregnancyNew Drugs Show Promise as First to Prevent MigraineMedication Adherence Up With Refill Synchronization ModelModified Vancomycin May Help Fight Bacterial ResistanceScientists Tweak Antibiotic to Boost Power Against 'Superbugs'New Cholesterol Fighting Meds Target Key GeneResearchers Say PDE5 Inhibitors Don't Cause MelanomaNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalU.S. Moves to Avert Shortage of Yellow Fever VaccineOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: StudyApril 29 Is National Prescription Drug Take Back DayERs Administering More Medications IntranasallyFDA Warns Against Children Taking Codeine, TramadolPhysicians Finding Ways to Work Around Cost of Rx MedicationsRuling Out Penicillin Allergy by Testing Inpatients Saves MoneyEpiPen Out-of-Pocket Costs More Than Doubled Over DecadeAACR: Regular Aspirin Use Linked to Lower Cancer MortalityFDA Approves Noctiva Nasal Spray for Nocturnal PolyuriaFDA Approves Odactra for House Dust Mite AllergiesHow Much Melatonin Is Really in That Supplement?
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

EpiPen Out-of-Pocket Costs More Than Doubled Over Decade

HealthDay News
by -- Robert Preidt
Updated: Apr 4th 2017

new article illustration

TUESDAY, April 4, 2017 (HealthDay News) -- Annual out-of-pocket costs for lifesaving EpiPens in the United States skyrocketed nearly 124 percent for many privately insured patients between 2007 and 2014, a new study finds.

An EpiPen is the most widely used epinephrine auto-injector. The pocket-sized device is needed when someone is having a life-threatening allergic reaction.

"The major concern is that these increases may lead patients to forgo filling EpiPen prescriptions due to cost, since having an EpiPen can mean the difference between life and death when serious allergic reactions occur," said study lead author Dr. Kao-Ping Chua.

Chua is an assistant professor of pediatrics and public health sciences at the University of Chicago. He and his colleagues analyzed nationwide data on people with employer-provided insurance.

Out-of-pocket costs for EpiPens rose from $33.80 in 2007 to $75.50 in 2014, even though there was little change in the rate of prescription fills, the researchers said.

About seven in 10 EpiPen users are commercially insured, the study authors noted.

The rising costs are due to aggressive drug company pricing and insurance policies that don't adequately protect patients financially, Chua and his colleagues said in a university news release.

"I have met families in the pediatric emergency department who have told me that cost prevents them from replacing their child's expired EpiPen every year," Chua said. "I also know a patient with a history of serious allergic reactions who only gets an EpiPen when her relative fills a prescription for an EpiPen two-pack and shares the extra one with her."

The pharmaceutical company Mylan bought the rights to EpiPen in 2007. After an outcry about soaring prices, it launched a $300 generic version last December.

Chua said that's not a real solution. "Many patients will still have substantial out-of-pocket spending for generic EpiPen because of the cost-sharing their insurance plan requires," he explained.

The study's senior author, Rena Conti, said current drug pricing practices erode patient and public health.

"The bottom line is that drug manufacturers and insurers should not force individuals and families to pay high amounts out-of-pocket for life-saving drugs like EpiPen," said Conti, an associate professor of pediatrics and public health sciences.

"Patients, physicians, and policymakers should advocate for fair pricing and adequate insurance coverage of life-saving emergency drugs," Conti concluded.

The study was published March 27 in the journal JAMA Internal Medicine.

More information

The U.S. National Library of Medicine has more on epinephrine injection.